Clinical Trial Update: Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

View source ↗

Summary

Post-marketing surveillance study of NerBloc (botulinum toxin type B) in patients switching from botulinum toxin type A for cervical dystonia. The study has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• NerBloc (botulinum toxin type B)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Cervical Dystonia | Status: COMPLETED